How a drug rep dealt with concerns that Zyprexa (olanzapine) causes obesity and diabetes: A video interview.
As an M.D. and pharmacology instructor I strongly believe that it’s really important that prescribers know the backstage of the pharmaceutical industry. In this video produced by PharmedOut, Shahram Ahari, a former drug rep from Eli Lilly; talks about the tactics he and his colleagues were instructed. The target was clear: to sell olanzapine (Zyprexa) […]